Pfizer is testing three extra-small doses of its vaccine in children under 5 after two shots didn't prove quite strong enough.
Pfizer is testing three extra-small doses of its vaccine in children under 5 after two shots didn't prove quite strong enough. Initial results had been expected last month but the company laid out the latest timeline Tuesday during its discussion of quarterlyCurrently in the U.S.
, only children ages 5 or older can be vaccinated, using Pfizer’s vaccine -- leaving 18 million younger tots unprotected.. Last week, it filed with the Food and Drug Administration data it hopes will prove two of its low-dose shots work in children younger than 5. Moderna also has filed FDA applications for older kids, although the agency hasn’t ruled on them.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Pfizer hopes to submit little-kid vaccine data by early JunePfizer now hopes to tell U.S. regulators how well its COVID-19 vaccine works in the littlest kids by early June
Read more »
Pfizer hopes to submit little-kid vaccine data by early JunePfizer now hopes to tell U.S. regulators how well its COVID-19 vaccine works in the littlest kids by early June.
Read more »
Pfizer in Q1 Profit Leap of 61%BAGGING CASH: Sales of Pfizer coronavirus vaccine and treatment pushed the drugmaker past expectations in the first quarter as profit grew 61 percent.
Read more »
Pfizer Q1 profit, revenue soar on COVID-19 vaccine salesCOVID-19 vaccine and treatment sales helped Pfizer breeze past Wall Street’s first-quarter expectations, as the drugmaker’s profit grew 61%.
Read more »
Pfizer Sales Soar on Covid-19 Vaccine SalesPfizer logged $25.7 billion in sales in the first-quarter, driven by sales of vaccine Comirnaty and Paxlovid, a pill aimed at reducing severe outcomes from Covid-19
Read more »
Pfizer beats Q1 estimates as COVID vaccine and antiviral boost revenuePfizer Inc. undefined posted better-than-expected first-quarter earnings on Tuesday, boosted by sales of its COVID-19 vaccine and antiviral Paxlovid. The...
Read more »